CRL Aug 2024 290.000 put
- Business Wire
Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research
WILMINGTON, Mass., June 04, 2024--Charles River announces the launch of its Virtual Control Groups (VCG) initiative with Sanofi to reduce the use of animals in research.
- Business Wire
Charles River Laboratories to Present at William Blair and Jefferies Conferences
WILMINGTON, Mass., June 03, 2024--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4th, at 10:00 a.m. CT (11:00 a.m. ET), and at the Jefferies Global Healthcare Conference on Wednesday, June 5th, at 10:00 a.m. ET. Management will present an overview of Charles River’s strategic focus, business developments, and recent trends.
- Zacks
Charles River (CRL) Launches Viral Vector Tech Transfer Program
Charles River's (CRL) new Fast Track and Modular frameworks facilitate product development continuity via accelerated process transfer to its viral vector Center of Excellence.
